MeSH D013967 - autoimmune thyroiditis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Levothyroxine | Levothyroxine |  | 2020-10-28 |  |  |
| Mylan | Levothyroxine | Ermeza | 2035-02-27 | 2022-04-29 |  |  |
| Levothyroxine | Levothyroxine |  | 2002-06-05 |  |  | |
| Lupin Research | Levothyroxine | Levothyroxine |  | 2019-01-18 |  |  |
| AbbVie | Levothyroxine | Synthroid |  | 2002-07-24 | $767 M | Y2021 |
| King Pharmaceuticals | Levothyroxine | Levoxyl | 2022-02-15 | 2001-05-25 |  |  |
| Genus Lifesciences | Levothyroxine | Levolet | 2038-03-23 | 2003-06-06 |  |  |
| Dr Reddys Laboratories | Levothyroxine | Levothyroxine |  | 2020-03-27 |  |  |
| Zydus Therapeutics | Levothyroxine | Levothyroxine |  | 2023-03-24 |  |  |
| Amneal Pharmaceuticals | Levothyroxine | Levothyroxine |  | 2019-02-19 | $135.22 M | Y2019 |
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
33%1/3
Phase 3
100%2/2
Approved: 2Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use